New Products: Gentler, safer alternative to chemical-based douches for vaginal odor
The FDA has approved a douching device that gently cleanses.
Results of a double-blind placebo-controlled study of women complaining of vaginal odor (but not due to infection or other medical causes), showed that participants who were randomized to WaterWorks experienced a significant reduction (P<.05) and/or elimination of vaginal odor compared to those using placebo. As always, advise patients to see you first to rule out common/treatable odor-causing vaginal infections. For more information or to purchase, call (800)-231-4928 or go to http://www.waterworkshealth.com/ . The product is not available in stores.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
